ESC Professional Premium Access

Aggressive combined pharmacotherapy for heart failure reduces new onset atrial fibrillation

Congress Session

About the speaker

Doctor Masaki Tokutome

Fukuoka Red Cross Hospital, Fukuoka (Japan)
0 follower

6 more presentations in this session

Type III collagen formation is significantly associated with risk of outcome in HFpEF patients but loses its significant association with underlying AF

Speaker: Ms E. Angeli (Copenhagen, DK)

Thumbnail

Baseline profile and results of atrial fibrillation ablation in patients with arrhythmia-induced cardiomyopathy

Speaker: Ms T. Gonzalez Ferrero (Santiago de Compostela, ES)

Thumbnail

Association of beta blocker use with new-onset heart failure and mortality in atrial fibrillation without pre-existing heart failure: the Fushimi AF registry

Speaker: Doctor M. Iguchi (Kyoto, JP) Doctor M. Akao (Kyoto, JP)

Thumbnail

ABC adherence and impact of optimal medical therapy in heart failure patients with atrial fibrillation

Speaker: Doctor N. Bonini (Modena, IT)

Thumbnail

Survival among people with heart failure and atrial fibrillation; a population cohort study

Speaker: Doctor N. Jones (Oxford, GB)

Thumbnail

Access the full session

Chronic heart failure and atrial fibrillation

Speakers: Doctor M. Tokutome, Ms E. Angeli, Ms T. Gonzalez Ferrero, Doctor M. Iguchi, Doctor M. Akao...
Thumbnail

About the event

Image

ESC Congress 2022

26 August - 29 August 2022

Sessions Presentations

This platform is supported by

logo Novo Nordisk